Stefanos Theoharis, PhD, was appointed chief business officer of Bone Therapeutics on March 26.
The Gosselies, Belgium-based bone cell company focuses on innovations in orthopedics and bone diseases.
Dr. Theoharis has more than 15 years of experience in mergers and acquisitions as well as research and development in the pharma and biotech industry.
He will lead Bone Therapeutics' corporate development activities, spearhead business strategy and advance the company's commercial strategies.
Dr. Theoharis will also guide Bone Therapeutics' business initiatives as it looks to advance its product pipeline through clinical development.